<DOC>
	<DOC>NCT01371006</DOC>
	<brief_summary>Obtain interaction data between BI 201335 and Efavirenz to guide dosing for each drug when administered together. To predict drug interaction between BI 201335 and Cyp 3A4 y using Midazolam as cyp 3A4 probe , Efavirenz as enzyme inducer and BI 201335 as enzyme inhibitor.</brief_summary>
	<brief_title>Evaluation of the Effect of Multiple Dosing With BI 201335 on CYP2B6 Metabolism and Effect of Multiple Dosing With Efavirenz on the Steady-state Pharmacokinetics of BI 201335 and on CYP3A4/5 Metabolism in Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Efavirenz</mesh_term>
	<criteria>Inclusion criteria: Healthy volunteers age 18 55 BMI (Body Mass Index) 18.5 29.9 Exclusion criteria: 1. Any finding on medical examination and ECG (Electrocardiography) deviating from normal 2. Active diseases 3. History of photosensitivity or rash</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>